Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
37.4M
-
Shares change
-
+628K
-
Total reported value, excl. options
-
$755M
-
Value change
-
+$13.4M
-
Put/Call ratio
-
0.22
-
Number of buys
-
70
-
Number of sells
-
-35
-
Price
-
$20.20
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2017
146 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2017.
NovoCure Ltd - Common Stock (NVCR) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.4M shares
of 112M outstanding shares and own 33.38% of the company stock.
Largest 10 shareholders include FMR LLC (8.07M shares), Vanguard Group Inc (4.61M shares), BlackRock Inc. (3.81M shares), StepStone Group LP (1.62M shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1.47M shares), FARALLON CAPITAL MANAGEMENT LLC (1.17M shares), STATE STREET CORP (1.13M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.08M shares), WADDELL & REED FINANCIAL INC (883K shares), and GREAT POINT PARTNERS LLC (879K shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.